Breaking News Instant updates and real-time market news.

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

, COST

Costco

$186.53

-1.75 (-0.93%)

17:30
12/14/17
12/14
17:30
12/14/17
17:30

On The Fly: After Hours Movers

UP AFTER EARNINGS: Jabil (JBL), up 2.7%... Costco (COST), up 1.4%... Centene (CNC), up 0.7%. ALSO HIGHER: Diana Containerships (DCIX), up 26.3% after Morgan Stanley (MS) reported a 5.3% passive stake in the company... DDR Corp. (DDR), up 8.7% after its board approved a plan to spin off a portfolio of 50 assets... RumbleON (RMBL), up 7.6% after it announced a strategic partnership with Sonic Automotive (SAH)... Hess Corporation (HES), up 5.9% after the Wall Street Journal reported that Elliott Management seeks to replace CEO John Hess... FormFactor (FORM), up 2% after the stock was upgraded to Strong Buy from Buy at Needham. DOWN AFTER EARNINGS: Oracle (ORCL), down 6.4%. ALSO LOWER: Verastem (VSTM), down 13.4% after it filed to sell $25M of common stock... Global Blood Therapeutics (GBT), down 3.8% after it filed to sell $100M in common stock.

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

COST

Costco

$186.53

-1.75 (-0.93%)

CNC

Centene

$99.02

-2.17 (-2.14%)

DCIX

Diana Containerships

$4.87

-0.37 (-7.06%)

MS

Morgan Stanley

$52.64

-0.54 (-1.02%)

DDR

DDR Corp.

$7.96

-0.11 (-1.36%)

RMBL

RumbleON

$5.30

-0.06 (-1.12%)

SAH

Sonic Automotive

$20.05

-0.95 (-4.52%)

HES

Hess Corp.

$42.67

-1.43 (-3.24%)

FORM

FormFactor

$14.90

-0.05 (-0.33%)

ORCL

Oracle

$50.19

0.14 (0.28%)

VSTM

Verastem

$3.65

-0.15 (-3.95%)

GBT

Global Blood Therapeutics

$39.40

1.05 (2.74%)

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

  • 09

    Jan

JBL Jabil Circuit
$27.45

-1.08 (-3.79%)

10/17/17
UBSW
10/17/17
NO CHANGE
Target $35
UBSW
Buy
Jabil Circuit strength in non-Apple business keeps it a Buy, says UBS
UBS analyst Steven Milunovich noted the recent weakness in Jabil Circuit (JBL) due to downgrades and its move higher over the last 12 months. The analyst said he would agree with the downgrades if it wasn't for the strength the company is showing in non-Apple (AAPL) products. He reiterated his driving point in his recommendation is that EMS is moving up the value chain as any maker of a tangible product needs help digitizing it. Milunovich reiterated his Buy rating and $35 price target on Jabil Circuit shares.
09/28/17
NEED
09/28/17
NO CHANGE
NEED
Jabil Circuit should be bought on weakness, says Needham
Needham analyst Sean Hannan says that Jabil (JBL) reported "fairly healthy" Q4 results. The analyst believes that the company is making progress in its effort to diversify its business away from Apple (AAPL), while its product mix and "general execution" are improving. He recommends buying the stock on weakness.
10/10/17
GSCO
10/10/17
DOWNGRADE
Target $26
GSCO
Sell
Jabil Circuit downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Mark Delaney downgraded Jabil Circuit (JBL) to Sell and lowered his price target for the shares to $26 from $28. Street expectations, which assume Jabil's earnings grow double digits year-over-year for both of the next two years, are overly optimistic, Delaney tells investors in a research note. He notes the company's earnings have been among the most volatile in his coverage universe and that the shares trade at a premium to their Apple-exposed peers.
10/10/17
10/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HSBC (HSBC) downgraded to Underperform from Neutral at Credit Suisse with analyst Sanjay Jain citing valuation. 2. Jabil Circuit (JBL) downgraded to Sell from Neutral at Goldman Sachs with analyst Mark Delaney saying street expectations, which assume Jabil's earnings grow double digits year-over-year for both of the next two years, are overly optimistic. 3. Carlyle Group (CG) downgraded to Neutral from Buy at Citi with analyst William Katz citing valuation with the shares up 60% year-to-date. 4. Eli Lilly (LLY) downgraded to Neutral from Outperform at Credit Suisse with analyst Vamil Divan saying the valuation looks full with the shares up 13% since mid-August. 5. Ralph Lauren (RL) downgraded to Sell from Hold at Miller Tabak. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COST Costco
$186.53

-1.75 (-0.93%)

11/30/17
STFL
11/30/17
NO CHANGE
Target $185
STFL
Buy
Costco price target raised to $185 from $179 at Stifel
Stifel analyst Mark Astrachan noted that Costco's (COST) core comp growth for the total company and in the U.S. both came in ahead of consensus expectations. He contends that accelerating comp growth is notable following the recent close of Amazon's (AMZN) deal to buy Whole Foods, as it indicates Costco's value proposition will allow it to coexist with Amazon. The analyst, who projects continued mid-single digit comp growth through at least FY19 at Costco, keeps a Buy rating on the stock and raised his price target to $185.
12/01/17
DADA
12/01/17
NO CHANGE
Target $85
DADA
Buy
Overstock.com offers a lot of value, says DA Davidson
DA Davidson analyst Tom Forte keeps his Buy rating and $85 price target on Overstock.com despite the 26% decline in stock price since Friday. Forte says his price target includes $58 valuation for the home e-commerce business based on the price that QVC (QVCA) paid for Zulily in 2015, and $27 for the Medici Ventures subsidiary. The analyst says that much like the "strategic" QVC acquisition, the purchase of Overstock.com e-commerce business could provide a lot of value to larger firms like T.J. Maxx (TJX) or Costco (COST).
12/04/17
JPMS
12/04/17
NO CHANGE
Target $200
JPMS
Overweight
Costco price target raised to $200 from $190 at JPMorgan
JPMorgan analyst Christopher Horvers raised his price target for Costco to $200 after increasing his estimates to reflect the November sales beat. Short investors may try to step in as compares get tougher and with the membership math coming back in focus, but this should pass as the company shows it can "comp the comp," Horvers tells investors in a research note. He keeps an Overweight rating on the shares.
12/04/17
MOFT
12/04/17
INITIATION
MOFT
Buy
Costco initiated with a Buy at MoffettNathanson
CNC Centene
$99.02

-2.17 (-2.14%)

12/06/17
COWN
12/06/17
NO CHANGE
COWN
Tax reform best for Medicare Advantage products, says Cowen
Cowen analyst Christine Arnold reviewed the tax reform implications for the managed care sector and believes the lower tax rate will be most beneficial for Medicare Advantage products as it could allow companies to offset a portion of the non-tax deductible headwind, allowing for stronger margins and/or enhanced benefits for seniors. She believes the lower tax rate would be most positive for Molina (MOH) and WellCare (WCG) given their domestic exposure, but it would also lead to a 15% earnings increase above her projections for Aetna (AET), Anthem (ANTM), Centene (CNC) and Humana (HUM).
11/03/17
FBCO
11/03/17
INITIATION
Target $102
FBCO
Neutral
Centene initiated with a Neutral at Credit Suisse
Credit Suisse analyst A.J. Rice started Centene with a Neutral rating and $102 price target.
10/17/17
BMOC
10/17/17
INITIATION
Target $120
BMOC
Outperform
Centene initiated with an Outperform at BMO Capital
BMO Capital analyst Matt Borsch initiated Centene with an Outperform rating and a price target of $120. Borsch cites attractive sector-relative valuation as well as multi-year growth expectations with revenue opportunity above $500B as high-acuity Medicaid populations are brought into managed care.
10/25/17
OPCO
10/25/17
NO CHANGE
Target $111
OPCO
Outperform
Centene price target raised to $111 from $105 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Centene to $111 from $105 following quarterly results. The analyst reiterates an Outperform rating on the shares.
DCIX Diana Containerships
$4.87

-0.37 (-7.06%)

11/13/17
WELS
11/13/17
NO CHANGE
WELS
Wells Fargo dropping coverage of Diana Containerships
Wells Fargo is dropping equity research coverage of Diana Containerships due to a reallocation of resources, among other factors.
MS Morgan Stanley
$52.64

-0.54 (-1.02%)

12/12/17
KBWI
12/12/17
UPGRADE
Target $59
KBWI
Outperform
Morgan Stanley upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded Morgan Stanley to Outperform and raised his price target for the shares to $59 from $52.
10/18/17
BMOC
10/18/17
NO CHANGE
Target $69
BMOC
Outperform
Morgan Stanley price target raised to $69 from $61 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Morgan Stanley to $69 after a Q3 top-line beat, saying the stock remains his top pick among the big six U.S. banks. Fotheringham is also raising his EPS forecast for FY17 to $3.54 from $3.41 to account for higher than previously modeled asset management fees, advisory fees, and equities trading revenues while maintaining an Outperform rating.
10/09/17
10/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Outperform from Market Perform at Wells Fargo with analyst Larry Biegelsen saying J&J is poised to reaccelerate its sales growth due to accretion from the Actelion acquisition, a "more measured" than expected impact from biosimilar competition, "solid performance" of key drugs and a pipeline that is "coming to fruition." 2. Morgan Stanley (MS) upgraded to Outperform from Neutral at Credit Suisse with analyst Susan Roth Katzke citing the over 10% total return potential in the shares. 3. Disney (DIS) upgraded to Top Pick from Outperform at RBC Capital with analyst Steven Cahall saying he thinks the company has reached a turning point with ESPN approaching less than 20% of earnings and "non-Media" Disney remaining a global leader in content that is executing well. 4. INC Research (INCR) upgraded to Buy from Hold at Jefferies analyst David Windley saying the recent share pullback provides a "compelling" entry point. 5. British American Tobacco (BTI) upgraded to Buy from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/17
FBCO
10/09/17
UPGRADE
Target $54
FBCO
Outperform
Morgan Stanley upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Susan Roth Katzke upgraded Morgan Stanley to Outperform from Neutral given the over 10% total return potential in the shares. The analyst also raised her price target on the shares to $54 from $49.
DDR DDR Corp.
$7.96

-0.11 (-1.36%)

11/30/17
STFL
11/30/17
INITIATION
Target $8.25
STFL
Hold
DDR Corp. initiated with a Hold at Stifel
Stifel started DDR Corp. with a Hold rating and $8.25 price target.
07/27/17
07/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Boeing (BA) was upgraded to Outperform from Neutral at Credit Suisse, to Buy from Neutral at BofA/Merrill, to Neutral from Sell at Goldman Sachs, and to Sector Perform from Underperform at RBC Capital. 2. State Street (STT) upgraded to In Line from Underperform at Evercore ISI with analyst Glenn Schorr citing improved execution and expects share to perform inline with the group despite continued fee pressure and competitive threats. 3. Vermilion Energy (VET) upgraded to Outperform from Sector Perform at RBC Capital. 4. DDR Corp. (DDR) upgraded to Buy from Hold at Deutsche Bank with analyst Vin Chao saying new management's progress towards balance sheet and disposition plans has much improved FFO visibility. 5. Rockwell Automation (ROK) upgraded to Neutral from Underweight at JPMorgan with analyst C. Stephen Tusa saying the company reported another quarter of "strong organic growth and solid fundamentals." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/04/17
EVER
12/04/17
DOWNGRADE
EVER
In Line
DDR Corp. downgraded to In Line from Outperform at Evercore ISI
10/03/17
BOSC
10/03/17
DOWNGRADE
BOSC
Underperform
DDR Corp. downgraded to Underperform from Neutral at Boenning & Scattergood
RMBL RumbleON
$5.30

-0.06 (-1.12%)

10/25/17
ROTH
10/25/17
INITIATION
Target $7.75
ROTH
Buy
RumbleON initiated with a Buy at Roth Capital
Roth Capital analyst Darren Aftahi started RumbleON with a Buy rating and $7.75 price target noting that as the company scales its business via increased marketing, it should be able to capture a meaningful portion of the about 800k annual used bikes bought and sold each year in the U.S.
SAH Sonic Automotive
$20.05

-0.95 (-4.52%)

10/19/17
BOFA
10/19/17
DOWNGRADE
BOFA
Underperform
Sonic Automotive downgraded to Underperform from Neutral at BofA/Merrill
02/23/17
BOFA
02/23/17
DOWNGRADE
Target $26
BOFA
Neutral
Sonic Automotive downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst John Murphy downgraded Sonic Automotive to Neutral saying the Q4 report was solid but 2017 earnings outlook implies a significant increase in investment for the EchoPark initiative and trimmed his estimates. Given the recent strength in shares, Murphy now views the stock as fairly valued and maintained its $26 price target.
10/19/17
10/19/17
DOWNGRADE
Target $19

Sonic Automotive downgraded to Underperform at BofA/Merrill
As previously reported, BofA/Merrill downgraded Sonic Automotive to Underperform from Neutral and cut its price target to $19 from $21. Analyst John Murphy said the US North American automotive cycle is entering a downturn which will pressure profits across the value chain and Sonic's SG&A leverage remains elevated due to new business initiatives which will continue to weigh on earnings.
10/04/17
KEYB
10/04/17
NO CHANGE
KEYB
KeyBanc cautious on AutoNation, Sonic Automotive after channel checks
Following our August channel checks, KeyBanc analyst Brett Hoselton reiterates an Overweight rating on Lithia Motors (LAD) and remains cautious on AutoNation's (AN) and Sonic Automotive's (SAH) earnings outlooks into Q3. The analyst believes AutoNation and Sonic Automotive could miss Q3 expectations by as much as 17%-23% given their outsized exposure to hurricane-impacted markets. He reiterates a Sector Weight rating on both stocks as he believes the anticipated tailwind of replacement demand should help shares weather the misses. Hoselton also raised his price target for Lithia Motors to $130 from $119.
HES Hess Corp.
$42.67

-1.43 (-3.24%)

09/14/17
09/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hertz (HTZ) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Adam Jonas citing the doubling of shares over the last three months and raised its price target to $14 from $12. 2. New Oriental Education (EDU) downgraded to Underweight from Neutral at JPMorgan with analyst Leon Chik saying the downgrade is "purely a valuation call." 3. McKesson (MCK) and AmerisourceBergen (ABC) were downgraded to Equal Weight from Overweight at Morgan Stanley. 4. Apache (APA) and Imperial Oil (IMO) were downgraded to Underweight from Neutral at JPMorgan, while Hess Corp. (HES) was downgraded to Neutral from Overweight. 5. Ryanair (RYAAY) downgraded to Reduce from Hold at HSBC with analyst Andrew Lobbenberg citing the ECJ ruling against the company's practice of employing flight crew on Irish labor contracts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/11/17
FBCO
12/11/17
INITIATION
FBCO
Underperform
Hess Corp. initiated with an Underperform at Credit Suisse
Credit Suisse analyst William Featherston initiated Hess Corp. with an Underperform rating and $38 price target.
07/17/17
WOLF
07/17/17
DOWNGRADE
WOLF
Peer Perform
Hess Corp. downgraded to Peer Perform from Outperform at Wolfe Research
09/14/17
JPMS
09/14/17
DOWNGRADE
Target $45
JPMS
Neutral
Hess Corp. downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Phil Gresh downgraded Hess Corp. to Neutral and lowered his price target for the shares to $45 from $52. The analyst highlights the company's "persistent" spending gap and "premium" valuation.
FORM FormFactor
$14.90

-0.05 (-0.33%)

12/14/17
NEED
12/14/17
UPGRADE
NEED
Strong Buy
FormFactor upgraded to Strong Buy from Buy at Needham
08/31/17
DADA
08/31/17
NO CHANGE
DADA
FormFactor risk/reward ratio positive, says DA Davidson
After meeting with FormFactor's management, DA Davidson analyst Thomas Diffely says that the company's "near term business trends continue to strengthen and the long term outlook has never been better," The analyst says that expectations for the company are "fairly modest," as the market has failed to fully appreciate significant improvements that FormFactor has made, and he expects the company's earnings to beat expectations. As a result, he thinks that the stock's risk/reward ratio is "bullish," and he keeps a Buy rating on the shares.
08/03/17
DADA
08/03/17
NO CHANGE
DADA
FormFactor 'firing on all cylinders,' says DA Davidson
DA Davidson analyst Thomas Diffely says that FormFactor is "firing on all cylinders," and reported its "best quarter in ten years." The analyst remains very upbeat on the stock and keeps a Buy rating.
06/29/17
NEED
06/29/17
NO CHANGE
Target $16
NEED
Buy
FormFactor recent selloff a buying opportunity, says Needham
Needham analyst Y. Edwin Mok noted that FormFactor provided a new target model with revenue of $650M and EPS of $1.50 in the 2019/20 timeframe and he believes the company will be able to deliver solid earnings growth even with its increased R&D expenses. The analyst, who sees the stock's recent selloff as a buying opportunity, keeps a Buy rating and $16 price target on FormFactor shares.
ORCL Oracle
$50.19

0.14 (0.28%)

12/06/17
RBCM
12/06/17
NO CHANGE
Target $53
RBCM
Outperform
Oracle price target lowered to $53 from $56 at RBC Capital
RBC Capital analyst Ross MacMillan lowered his price target on Oracle to $53, saying that his proprietary customer survey suggests that the company's cloud revenue and margins are slightly below consensus. MacMillan says that while the findings suggest that many of Oracle's customers find its technology stack remains relevant, modeling modest spending increases over the next 3 years, many customers also indicate that they do not use Oracle cloud services today and are unlikely to do so in the future. The analyst keeps his Outperform rating on Oracle, forecasting a 12% revenue growth and 42% operating margins.
11/09/17
UBSW
11/09/17
DOWNGRADE
Target $55
UBSW
Neutral
Oracle assumed with a Neutral from Buy at UBS
UBS analyst Jennifer Swanson Lowe downgraded Oracle to Neutral and lowered her price target for the shares to $55 from $57 after assuming coverage of the name. The analyst believes the stock at current levels leaves little room for error as the company transitions to the cloud. Further, she believes Street estimates do not fully reflect the near-term risk to margins or growth as the model shifts.
11/03/17
BMOC
11/03/17
NO CHANGE
Target $40
BMOC
Market Perform
Teradata price target raised to $40 from $32 at BMO CapitalVMware
BMO Capital analyst Keith Bachman raised his price target on Teradata (TDC) to $40, saying the company's turnaround is driven by the buying capacity of existing customers. While Bachman believes the recurring product revenue growth is sustainable, he sees Oracle (ORCL) and VMware (VMW) as more attractively valued, keeping a Market Perform rating on Teradata.
12/06/17
BARD
12/06/17
NO CHANGE
BARD
Baird identifies 13 areas of opportunity for Blockchain technology
Baird analyst Colin Sebastian has identified 13 areas of opportunity for Blockchain technology to have an impact. He sees Blockchain as platform enhancing in IoT, virtual goods, cloud storage, online gaming, and eSports. He sees the Blockchain as platform disruptive in online marketing, e-commerce, ride-sharing, digital music/media, and peer-to-peer payments. Sebastian believes technology companies will be talking more about it as they become more engaged in the areas he has mentioned and noted companies such as Amazon (AMZN), Oracle (ORCL) and VMware (VMW) have already recruited engineers with Blockchain experience.
VSTM Verastem
$3.65

-0.15 (-3.95%)

09/06/17
CANT
09/06/17
UPGRADE
Target $17
CANT
Verastem upgraded to Overweight after duvelisib data at Cantor
As previously reported, Cantor Fitzgerald analyst Mara Goldstein upgraded Verastem to Overweight from Neutral after the company reported Phase 3 DUO study data on duvelisib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma that was "squarely positive" and suggests a viable commercial opportunity. The analyst, who predicts that duvelisib can capture a reasonable market share in both high risk and low/medium risk patients with relapsed/refractory CLL, raised her price target on Verastem shares to $17 from $2.
12/11/17
OPCO
12/11/17
NO CHANGE
Target $15
OPCO
Outperform
Verastem price target raised to $15 from $6 at Oppenheimer
Oppenheimer analyst Leah Rush Cann raised her price target for Verastem to $15 from $6 to reflect decreased risk of failure, now that details of the DUO data are released. Based on the balance of efficacy and adverse events reported from the DUO study, the analyst continues to expect that Verastem will launch duvelisib in 2019, and it will be the primary revenue and earnings driver for the company. The analyst reiterates an Outperform rating on the shares.
11/30/17
ROTH
11/30/17
INITIATION
Target $12
ROTH
Buy
Verastem initiated with a Buy at Roth Capital
Roth Capital analyst Jotin Marango initiated Verastem with a Buy rating and $12 price target, as he believes full CLL data from the DUO pivotal study at ASH next week should bolster investor confidence in duvelisib ahead of an NDA filing he sees as likely in the first quarter of 2018.
09/06/17
CANT
09/06/17
UPGRADE
CANT
Overweight
Verastem upgraded to Overweight from Neutral at Cantor
GBT Global Blood Therapeutics
$39.40

1.05 (2.74%)

12/12/17
OPCO
12/12/17
NO CHANGE
Target $79
OPCO
Outperform
Global Blood Therapeutics price target raised to $79 from $53 at Oppenheimer
Oppenheimer analyst Mark Breidenbach raised his price target for Global Blood Therapeutics to $79 from $53 given new clinical data and improved clarity on the performance of the Patient Reported Outcome instrument. The analyst reiterates an Outperform rating on the shares.
12/12/17
EAMC
12/12/17
NO CHANGE
Target $58
EAMC
Global Blood Therapeutics weakness a buying opportunity, says Empire
Empire said Global Blood Therapeutics' weakness seems to be related to both enthusiasm for ASH presentations on potential curative SCD gene therapies and a misunderstanding about two deaths in a voxelotor compassionate use program that were deemed unrelated to voxelotor therapy. The firm, which does not consider potential gene therapies to cure SCD as a major threat to voxelotor, keeps a $58 price target on the stock and views the post-ASH weakness as a buying opportunity.
12/14/17
NEED
12/14/17
NO CHANGE
Target $70
NEED
Buy
Global Blood Therapeutics price target raised to $70 from $51 at Needham
Needham analyst Danielle Brill raised her price target on Global Blood Therapeutics to $70, saying the company is her top pick going into 2018. Brill notes her "conviction for a positive outcome from Part A of the Phase 3 HOPE trial" in the first half of next year after the latest data updates at ASH, as the safety and efficacy profile of voxeletor remain encouraging. The analyst keeps her Buy rating on Global Blood Therapeutics, adding that the recent pullback in shares creates an attractive opportunity for investors.
12/11/17
MSCO
12/11/17
NO CHANGE
Target $55
MSCO
Overweight
Global Blood Therapeutics ASH update 'solid,' says Morgan Stanley
Morgan Stanley analyst Matthew Harrison called the interim data presented by Global Blood Therapeutics for its Phase 2a trial of GBT440 in adolescents "solid" and encouraging in terms of the potential response in Phase 3. He maintains an Overweight rating and $55 price target on Global Blood Therapeutics shares, which are down 6% to $43 in pre-market trading.

TODAY'S FREE FLY STORIES

10:30
08/16/18
08/16
10:30
08/16/18
10:30
General news
EIA natural gas storage change for week ending August 10 »

Gas inventories 33 Bcf…

CTL

CenturyLink

$22.96

0.48 (2.14%)

10:30
08/16/18
08/16
10:30
08/16/18
10:30
Options
Sweep buyer of CenturyLink in the money puts as shares reach 52-week highs »

Sweep buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBNY

Signature Bank

$114.29

1.53 (1.36%)

10:29
08/16/18
08/16
10:29
08/16/18
10:29
Hot Stocks
Signature Bank announces special meeting to approve stock buyback program »

Signature Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 29

    Oct

10:20
08/16/18
08/16
10:20
08/16/18
10:20
General news
Market opens sharply higher on renewed trade hopes »

Stock futures were…

ROK

Rockwell Automation

$172.79

1.13 (0.66%)

10:20
08/16/18
08/16
10:20
08/16/18
10:20
Options
Call buyer in Rockwell as shares see strength »

Call buyer in Rockwell as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/16/18
08/16
10:17
08/16/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBH

Zimmer Biomet

$122.72

0.03 (0.02%)

10:16
08/16/18
08/16
10:16
08/16/18
10:16
Hot Stocks
KFx Medical, Zimmer Biomet enter into license agreement »

KFx Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/16/18
08/16
10:16
08/16/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/16/18
08/16
10:15
08/16/18
10:15
General news
Breaking General news story  »

Week of 8/10 EIA Natural…

POST

Post Holdings

$96.51

1.73 (1.83%)

, SYK

Stryker

$168.57

1.735 (1.04%)

10:12
08/16/18
08/16
10:12
08/16/18
10:12
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

POST

Post Holdings

$96.51

1.73 (1.83%)

SYK

Stryker

$168.57

1.735 (1.04%)

AVEO

Aveo Pharmaceuticals

$2.26

0.085 (3.91%)

UXIN

Uxin

$5.58

0.315 (5.98%)

ACRX

AcelRx

$2.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 23

    Aug

  • 04

    Sep

  • 12

    Sep

AZN

AstraZeneca

$38.35

-0.1 (-0.26%)

, CX

Cemex

$6.80

0.005 (0.07%)

10:12
08/16/18
08/16
10:12
08/16/18
10:12
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

AZN

AstraZeneca

$38.35

-0.1 (-0.26%)

CX

Cemex

$6.80

0.005 (0.07%)

CVE

Cenovus Energy

$8.97

0.015 (0.17%)

NANO

Nanometrics

$41.46

-3.74 (-8.27%)

COTY

Coty

$11.37

-0.06 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 21

    Aug

  • 25

    Aug

  • 28

    Aug

  • 09

    Oct

LULU

Lululemon

$127.75

1.27 (1.00%)

, KMB

Kimberly-Clark

$117.47

1 (0.86%)

10:12
08/16/18
08/16
10:12
08/16/18
10:12
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

LULU

Lululemon

$127.75

1.27 (1.00%)

KMB

Kimberly-Clark

$117.47

1 (0.86%)

ERJ

Embraer

$19.49

0.855 (4.59%)

FTI

TechnipFMC

$28.19

0.59 (2.14%)

AVLR

Avalara

$37.90

3.22 (9.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 30

    Aug

  • 12

    Sep

RADA

RADA Electronic

$2.55

0.01 (0.39%)

10:10
08/16/18
08/16
10:10
08/16/18
10:10
Initiation
RADA Electronic initiated  »

RADA Electronic initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$43.82

0.35 (0.81%)

10:10
08/16/18
08/16
10:10
08/16/18
10:10
Options
Another utility name with one day call buying »

Another utility name with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$127.16

0.68 (0.54%)

, KMB

Kimberly-Clark

$117.91

1.44 (1.24%)

10:06
08/16/18
08/16
10:06
08/16/18
10:06
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

LULU

Lululemon

$127.16

0.68 (0.54%)

KMB

Kimberly-Clark

$117.91

1.44 (1.24%)

COTY

Coty

$11.34

-0.09 (-0.79%)

ATVI

Activision Blizzard

$69.47

0.2 (0.29%)

NKE

Nike

$80.12

0.56 (0.70%)

UA

Under Armour

$19.22

0.19 (1.00%)

UAA

Under Armour

$20.79

0.2 (0.97%)

VFC

VF Corp.

$92.13

-0.17 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 30

    Aug

  • 04

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

C

Citi

$69.49

0.85 (1.24%)

, CAT

Caterpillar

$134.50

2.49 (1.89%)

10:03
08/16/18
08/16
10:03
08/16/18
10:03
Hot Stocks
Citi Retail Services announces long-term agreement with Caterpillar Financial »

Citi Retail Services (C)…

C

Citi

$69.49

0.85 (1.24%)

CAT

Caterpillar

$134.50

2.49 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

GTN

Gray Television

$16.40

-0.05 (-0.30%)

, CBS

CBS

$52.89

0.09 (0.17%)

10:02
08/16/18
08/16
10:02
08/16/18
10:02
Hot Stocks
Gray Television to sell WSWG-TV in Albany, Georgia »

Gray Television (GTN)…

GTN

Gray Television

$16.40

-0.05 (-0.30%)

CBS

CBS

$52.89

0.09 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 27

    Sep

GM

General Motors

$36.49

0.55 (1.53%)

, RDS.A

Royal Dutch Shell

$63.18

0.95 (1.53%)

10:02
08/16/18
08/16
10:02
08/16/18
10:02
Hot Stocks
GM, Shell deliver nationwide in-dash fuel payment »

Shell Oil Company (RDS.A)…

GM

General Motors

$36.49

0.55 (1.53%)

RDS.A

Royal Dutch Shell

$63.18

0.95 (1.53%)

RDS.B

Royal Dutch Shell

$65.20

0.92 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$9.12

-0.63 (-6.46%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -6.6% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNL

Global Net Lease

$20.61

-1.47 (-6.66%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Global Net Lease falls -6.6% »

Global Net Lease is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

DDS

Dillard's

$74.93

-8.05 (-9.70%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Dillard's falls -9.8% »

Dillard's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATV

Acorn International

$17.84

(0.00%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Acorn International rises 10.1% »

Acorn International is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$128.36

0.3 (0.23%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Options
Electronic Arts with repeat option action late yesterday »

Electronic Arts with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

WUBA

58.com

$65.22

6.63 (11.32%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
58.com rises 11.2% »

58.com is up 11.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 10

    Sep

BGG

Briggs & Stratton

$20.54

2.13 (11.57%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Briggs & Stratton rises 11.7% »

Briggs & Stratton is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.